What is the share price of Amrutanjan Health Care Ltd (AMRUTANJAN) today?
The share price of AMRUTANJAN as on 9th July 2025 is ₹720. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Amrutanjan Health Care Ltd (AMRUTANJAN) share?
The past returns of Amrutanjan Health Care Ltd (AMRUTANJAN) share are- Past 1 week: -0.31%
- Past 1 month: -0.06%
- Past 3 months: 13.06%
- Past 6 months: -0.30%
- Past 1 year: -9.73%
- Past 3 years: -10.02%
- Past 5 years: 99.24%
What are the peers or stocks similar to Amrutanjan Health Care Ltd (AMRUTANJAN)?
The peers or stocks similar to Amrutanjan Health Care Ltd (AMRUTANJAN) include:What is the dividend yield % of Amrutanjan Health Care Ltd (AMRUTANJAN) share?
The current dividend yield of Amrutanjan Health Care Ltd (AMRUTANJAN) is 0.65.What is the market cap of Amrutanjan Health Care Ltd (AMRUTANJAN) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Amrutanjan Health Care Ltd (AMRUTANJAN) is ₹2049.74 Cr as of 9th July 2025.What is the 52 week high and low of Amrutanjan Health Care Ltd (AMRUTANJAN) share?
The 52-week high of Amrutanjan Health Care Ltd (AMRUTANJAN) is ₹862.60 and the 52-week low is ₹544.10.What is the PE and PB ratio of Amrutanjan Health Care Ltd (AMRUTANJAN) stock?
The P/E (price-to-earnings) ratio of Amrutanjan Health Care Ltd (AMRUTANJAN) is 40.33. The P/B (price-to-book) ratio is 7.11.Which sector does Amrutanjan Health Care Ltd (AMRUTANJAN) belong to?
Amrutanjan Health Care Ltd (AMRUTANJAN) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Amrutanjan Health Care Ltd (AMRUTANJAN) shares?
You can directly buy Amrutanjan Health Care Ltd (AMRUTANJAN) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Amrutanjan Health Care Ltd
AMRUTANJAN Share Price
AMRUTANJAN Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
AMRUTANJAN Performance & Key Metrics
AMRUTANJAN Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
40.31 | 7.11 | 0.65% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
36.69 | 6.41 | 0.79% |
AMRUTANJAN Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
AMRUTANJAN Company Profile
Amrutanjan Health Care Limited is engaged in offering ayurvedic balm for headaches, cold and cough. The Company operates through three segments: over-the-counter (OTC) products, beverages and others.
AMRUTANJAN Forecast
AMRUTANJAN Forecasts
AMRUTANJAN
AMRUTANJAN
Income
Balance Sheet
Cash Flow
AMRUTANJAN Income Statement
AMRUTANJAN Income Statement
Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 214.14 | 227.88 | 260.36 | 269.80 | 344.16 | 421.22 | 394.18 | 437.58 | 469.50 | 469.49 | ||||||||||
Raw Materials | 85.69 | 94.01 | 122.16 | 124.05 | 135.18 | 185.96 | 183.71 | 209.67 | 393.62 | 393.61 | ||||||||||
Power & Fuel Cost | 1.66 | 1.70 | 1.87 | 2.02 | 1.76 | 2.66 | 3.06 | 3.84 | ||||||||||||
Employee Cost | 29.67 | 33.85 | 33.36 | 39.36 | 41.70 | 48.23 | 48.81 | 47.69 | ||||||||||||
Selling & Administrative Expenses | 54.33 | 53.14 | 59.96 | 61.45 | 64.72 | 84.68 | 86.95 | 89.23 | ||||||||||||
Operating & Other expenses | 6.69 | 9.10 | 4.95 | 3.77 | 14.64 | 4.74 | 12.57 | 18.89 | ||||||||||||
EBITDA | 36.10 | 36.08 | 38.06 | 39.15 | 86.16 | 94.95 | 59.08 | 68.26 | 75.88 | 75.88 | ||||||||||
Depreciation/Amortization | 2.05 | 2.91 | 3.16 | 4.36 | 3.67 | 3.80 | 5.21 | 6.06 | 6.53 | 6.52 | ||||||||||
PBIT | 34.05 | 33.17 | 34.90 | 34.79 | 82.49 | 91.15 | 53.87 | 62.20 | 69.35 | 69.36 | ||||||||||
Interest & Other Items | 0.25 | 0.31 | 0.20 | 0.34 | 0.59 | 0.58 | 0.22 | 0.25 | 0.22 | 0.22 | ||||||||||
PBT | 33.80 | 32.86 | 34.70 | 34.45 | 81.90 | 90.57 | 53.65 | 61.95 | 69.13 | 69.14 | ||||||||||
Taxes & Other Items | 11.99 | 12.91 | 10.17 | 9.37 | 20.71 | 23.39 | 13.81 | 16.97 | 18.30 | 18.29 | ||||||||||
Net Income | 21.81 | 19.95 | 24.53 | 25.08 | 61.19 | 67.18 | 39.84 | 44.98 | 50.83 | 50.85 | ||||||||||
EPS | 7.46 | 6.83 | 8.39 | 8.58 | 20.93 | 22.98 | 13.63 | 15.47 | 17.58 | 17.59 | ||||||||||
DPS | 1.93 | 1.53 | 2.15 | 2.10 | 4.20 | 4.60 | 4.60 | 4.60 | 4.60 | 4.60 | ||||||||||
Payout ratio | 0.26 | 0.22 | 0.26 | 0.24 | 0.20 | 0.20 | 0.34 | 0.30 | 0.26 | 0.26 |
AMRUTANJAN Company Updates
Investor Presentation
AMRUTANJAN Stock Peers
AMRUTANJAN Past Performance & Peer Comparison
AMRUTANJAN Past Performance & Peer Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Amrutanjan Health Care Ltd | 40.33 | 7.11 | 0.65% |
Sun Pharmaceutical Industries Ltd | 36.72 | 5.54 | 0.96% |
Cipla Ltd | 22.80 | 3.84 | 1.07% |
Torrent Pharmaceuticals Ltd | 58.83 | 14.81 | 0.18% |
AMRUTANJAN Stock Price Comparison
Compare AMRUTANJAN with any stock or ETFAMRUTANJAN Holdings
AMRUTANJAN Shareholdings
AMRUTANJAN Promoter Holdings Trend
AMRUTANJAN Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
AMRUTANJAN Institutional Holdings Trend
AMRUTANJAN Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
AMRUTANJAN Shareholding Pattern
AMRUTANJAN Shareholding Pattern
AMRUTANJAN Shareholding History
AMRUTANJAN Shareholding History
Mutual Funds Invested in AMRUTANJAN
Mutual Funds Invested in AMRUTANJAN
No mutual funds holding trends are available
Top 2 Mutual Funds holding Amrutanjan Health Care Ltd
Funds (Top 2) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 5.0932% | Percentage of the fund’s portfolio invested in the stock 0.64% | Change in the portfolio weight of the stock over the last 3 months 0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 36/83 (+30) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 2.4792% | Percentage of the fund’s portfolio invested in the stock 2.51% | Change in the portfolio weight of the stock over the last 3 months 0.13% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 10/31 (+1) |
Compare 3-month MF holding change on Screener
smallcases containing AMRUTANJAN stock
smallcases containing AMRUTANJAN stock
Looks like this stock is not in any smallcase yet.
AMRUTANJAN Events
AMRUTANJAN Events
AMRUTANJAN Dividend Trend
AMRUTANJAN has increased or maintained dividend levels over the last 5 years
Current dividend yield is 0.65%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹6.49 every year
Dividends
Corp. Actions
Announcements
Legal Orders
AMRUTANJAN Dividend Trend
AMRUTANJAN has increased or maintained dividend levels over the last 5 years
Current dividend yield is 0.65%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹6.49 every year
AMRUTANJAN Upcoming Dividends
AMRUTANJAN Upcoming Dividends
No upcoming dividends are available
AMRUTANJAN Past Dividends
AMRUTANJAN Past Dividends
Cash Dividend
Ex DateEx DateFeb 18, 2025
Dividend/Share
₹1.00
Ex DateEx Date
Feb 18, 2025
Cash Dividend
Ex DateEx DateNov 22, 2024
Dividend/Share
₹1.00
Ex DateEx Date
Nov 22, 2024
Cash Dividend
Ex DateEx DateSep 13, 2024
Dividend/Share
₹2.60
Ex DateEx Date
Sep 13, 2024
Cash Dividend
Ex DateEx DateFeb 20, 2024
Dividend/Share
₹1.00
Ex DateEx Date
Feb 20, 2024
Cash Dividend
Ex DateEx DateNov 23, 2023
Dividend/Share
₹1.00
Ex DateEx Date
Nov 23, 2023
AMRUTANJAN Stock News & Opinions
AMRUTANJAN Stock News & Opinions
Net profit of Amrutanjan Health Care rose 11.13% to Rs 15.18 crore in the quarter ended March 2025 as against Rs 13.66 crore during the previous quarter ended March 2024. Sales rose 6.57% to Rs 135.41 crore in the quarter ended March 2025 as against Rs 127.06 crore during the previous quarter ended March 2024. For the full year,net profit rose 13.03% to Rs 50.83 crore in the year ended March 2025 as against Rs 44.97 crore during the previous year ended March 2024. Sales rose 7.26% to Rs 451.82 crore in the year ended March 2025 as against Rs 421.23 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales135.41127.06 7 451.82421.23 7 OPM %13.0712.78 -12.8812.30 - PBDT22.4821.14 6 75.6668.00 11 PBT20.8619.61 6 69.1361.94 12 NP15.1813.66 11 50.8344.97 13 Powered by Capital Market - Live
Amrutanjan Health Care announced that the Board of Directors of the Company at its meeting held on 15 May 2025, inter alia, have recommended the final dividend of Rs 2.6 per equity Share (i.e. 260%) , subject to the approval of the shareholders.Powered by Capital Market - Live
Amrutanjan Health Care will hold a meeting of the Board of Directors of the Company on 15 May 2025.Powered by Capital Market - Live
Net profit of Amrutanjan Health Care rose 10.32% to Rs 19.25 crore in the quarter ended December 2024 as against Rs 17.45 crore during the previous quarter ended December 2023. Sales rose 4.92% to Rs 122.75 crore in the quarter ended December 2024 as against Rs 116.99 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales122.75116.99 5 OPM %19.0218.45 - PBDT27.6525.29 9 PBT25.9923.71 10 NP19.2517.45 10 Powered by Capital Market - Live
Amrutanjan Health Care announced that the Board of Directors of the Company at its meeting held on 12 February 2025, inter alia, have recommended the Second Interim dividend of Rs 1 per equity Share (i.e. 100%) , subject to the approval of the shareholders.Powered by Capital Market - Live
Amrutanjan Health Care will hold a meeting of the Board of Directors of the Company on 12 February 2025.Powered by Capital Market - Live
Amrutanjan Health Care announced that the Board of Directors of the Company at its meeting held on 12 November 2024, inter alia, have recommended the first interim dividend of Rs 1 per equity Share (i.e. 100%) , subject to the approval of the shareholders.Powered by Capital Market - Live
Net profit of Amrutanjan Health Care rose 72.26% to Rs 11.80 crore in the quarter ended September 2024 as against Rs 6.85 crore during the previous quarter ended September 2023. Sales rose 10.68% to Rs 109.92 crore in the quarter ended September 2024 as against Rs 99.31 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales109.9299.31 11 OPM %12.376.89 - PBDT17.5910.76 63 PBT15.949.21 73 NP11.806.85 72 Powered by Capital Market - Live
Amrutanjan Health Care will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live
Amrutanjan Health Care announced that the 87th Annual General Meeting (AGM) of the company will be held on 23 September 2024.Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 11.72%, vs industry avg of 10.1%
Over the last 5 years, market share stayed at 0.11%
Over the last 5 years, net income has grown at a yearly rate of 15.18%, vs industry avg of 20.04%